Iketani, S., Forouhar, F., Liu, H., Hong, S. J., Lin, F., Nair, M. S., . . . Ho, D. D. (2021). Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors. Nat Commun.
Chicago Stili AlıntıIketani, Sho, et al. "Author Correction: Lead Compounds for the Development of SARS-CoV-2 3CL Protease Inhibitors." Nat Commun 2021.
MLA AlıntıIketani, Sho, et al. "Author Correction: Lead Compounds for the Development of SARS-CoV-2 3CL Protease Inhibitors." Nat Commun 2021.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..